CohBar to Announce 2021 Fourth Quarter and Full-Year Financial Results and Provide Business Update on March 29, 2022
Company to host conference call and webcast at 5:00 p.m. ET MENLO PARK, Calif., March…
News
Quoin Pharmaceuticals Announces Submission of IND for its Lead Asset, QRX003, for Netherton Syndrome
Quoin Anticipates Initiating Clinical Testing in Q2 2022 ASHBURN, Va., March 15, 2022 (GLOBE NEWSWIRE)…
Wave Life Sciences to Highlight RNA Base Editing Modality and Alpha-1 Antitrypsin Deficiency Program at Upcoming Scientific and Industry Meetings
Presentation at OPT 2022 to highlight AATD program, including reduction of liver aggregates with repeat…
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on March 22, 2022
CAMBRIDGE, Mass., March 15, 2022 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced…
Biomea Fusion to Present at Oppenheimer’s 32nd Annual Virtual Healthcare Conference
REDWOOD CITY, Calif., March 15, 2022 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (Nasdaq: BMEA), a…
Caladrius Biosciences to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on Tuesday, March 22, 2022, at 4:30 p.m. Eastern Time
BASKING RIDGE, N.J., March 15, 2022 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius”…
ExCellThera announces new data to be presented at the EBMT 2022 annual meeting
MONTRÉAL, March 15, 2022 (GLOBE NEWSWIRE) — ExCellThera Inc. (ExCellThera), a clinical-stage cell expansion and…
Trusting Heart Blood Center Holds Ribbon Cutting Ceremony for Opening of its Second Platelet Donation Site
Photo 1 Reception at New Trusting Heart Blood Center – Raleigh, North Carolina Photo 2…
Mersana Therapeutics to Present an Analysis from the Expansion Cohort of the Phase 1 Trial of Upifitamab Rilsodotin at the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer
CAMBRIDGE, Mass., March 15, 2022 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical…
First Participants Dosed in Phase 2a Study of Pan-Antiviral Nasal Spray
ENA Respiratory begins influenza challenge study for fast-acting nasal spray INNA-051, designed to boost innate…
PepGen Announces Approval by Health Canada of CTA to Begin First in Human Trials of PGN-EDO51 to Treat Duchenne Muscular Dystrophy
Updates on preclinical data and the clinical development plan will be presented at the Muscular…
Neoleukin Therapeutics Announces Appointment of Donna Cochener as General Counsel
SEATTLE, March 15, 2022 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company…
Eyenovia Announces Positive Study Results Demonstrating that its Optejet® Delivery Technology Reduces Conjunctival Cell Toxicity from Preserved Ophthalmic Solutions to a Level Comparable with Non-Preserved Solutions
Study conducted with Tufts Medical Center represents a breakthrough showing that Microdose Array Print (MAP™)…
Elicio Therapeutics Moves into Boston’s Seaport District and Provides Update on Programs
The Company has moved from Cambridge, MA to a new, larger space in the Seaport…
Werewolf Therapeutics Announces Upcoming Presentations at AACR 2022 Annual Meeting
CAMBRIDGE, Mass., March 15, 2022 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”)…
Longeveron to Present at Oppenheimer 32nd Annual Healthcare Conference
MIAMI, March 15, 2022 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical…
Coherus BioSciences Appoints Rosh Dias, MD, MRCP, Chief Medical Officer
– Dr. Dias is a biotech and pharma industry executive with more than 20 years…
Ovid Therapeutics Reports Business Update, Fourth Quarter and Full Year 2021 Financial Results
Ovid executing on its strategy to build a leading epilepsy pipeline OV329 expected to enter…
INmune Bio, Inc. Announces Nine Data Presentations at AD/PD™ 2022 – International Conference on Alzheimer’s and Parkinson’s Diseases
Conference Provides First Exposure of EU and UK AD Experts to INmune Bio’s Approach of…
Achieve Life Sciences Announces Cytisinicline Presentation at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
SEATTLE and VANCOUVER, British Columbia, March 15, 2022 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc….